Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Irvine, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eledon Pharmaceuticals, Inc. has filed 608 SEC EDGAR filings since 18 Jun 2007

SEC filing history

Showing 376-400 of 605 matching filings.

Per page
25
Current page
16
4

FORM 4 SUBMISSION

Filing date
14 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
14 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

SCHEDULE 13D/A - AMENDMENT NO. 3 (EXIT FILING)

Filing date
15 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K FOR Q1 2018 EARNINGS RELEASE

Filing date
11 May 2018
Reporting date
11 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

SCHEDULE 13D/A - AMENDMENT NO. 2

Filing date
02 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36620

DEFA14A

Filing date
30 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36620

DEF 14A

Filing date
30 Apr 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

SC 13D/A

Filing date
17 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K Q4 2017 EARNINGS RELEASE

Filing date
02 Apr 2018
Reporting date
30 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Mar 2018
Reporting date
09 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

AMENDMENT NO. 1

Filing date
19 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Mar 2018
Reporting date
13 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Mar 2018
Reporting date
13 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Mar 2018
Reporting date
13 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88334

SC 13G filing

Filing date
13 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K - ATM COMPLETION

Filing date
12 Mar 2018
Reporting date
09 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

SCHEDULE 13D/A - AMENDMENT NO. 1

Filing date
08 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K INVESTOR PRESENTATION

Filing date
29 Nov 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
08 Nov 2017
Reporting date
08 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
06 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .